Enliven Therapeutics. Every tracked FinTwit mention of $ELVN, newest first. 15 mentions since the first on Dec 9, 2025. See the price chart.
March 2026 · 5 mentions
Mar 25
Jacob Plieth — $MRK, a company with no CML presence, buys $TERN, a company that only pivoted to CML 2 years ago. And other surprises, via @apexonco -> https://t.co/MtOjGJmTfd $ELVN $NVS $PFE $…↗
Mar 25
Jacob Plieth — Wouldn't it be funny if we found out that, say in mid-2025 (valuation ~$1bn, before $TERN was even a thing), $ELVN received a takeover approach but turned it down.↗
Mar 25
Jacob Plieth — And obviously $ELVN +20% in the PM. Because why not!↗
Mar 25
Jacob Plieth — @christymaginn $ELVN still listed as recruiting, per CT-gov.↗
Mar 25
Jacob Plieth — Worth $6bn to $MRK? $TERN data from #ASH25 $ELVN↗
January 2026 · 5 mentions
Jan 9
Jacob Plieth — Still not convinced by $ELVN? Via @ApexOnco -> https://t.co/98kEmPBZfk $TERN↗
Jan 9
Jacob Plieth — @masonat7 Exactly! (You could have added "said no $ELVN sellside analyst ever" to that comment LOL)↗
Jan 9
Jacob Plieth — @houndcl @JusticeforB_MD V little disclosed by $ELVN yesterday.↗
Jan 9
Jacob Plieth — Notable that $ELVN didn't split out the 60mg from the 120mg results. Did 60mg actually do better than 80mg?? All quite bizarre, but stock +50% so what do I know! $TERN↗
December 2025 · 5 mentions
Dec 12
Jacob Plieth — @NotJanetYellen7 So this idea that $ELVN comes after $TERN, that's been a thing for how long? A week?↗
Dec 11
Jacob Plieth — $ELVN Wait, THE Rick Fair? Of $BLCM fame?↗
Dec 9
Jacob Plieth — $TERN wins #ASH25, via @ApexOnco -> https://t.co/6mQGwnSUq8 $ELVN $NVS↗
Dec 9
Jacob Plieth — $ELVN vs $TERN: game over? #ASH25 https://t.co/2jLNdqFSFM↗
Jan 9
Jacob Plieth — OK then, let's play the "selected doses" game $ELVN $TERN https://t.co/qoY08k7Lfi↗
Dec 9
Jacob Plieth — $TERN looks like the winner of #ASH25 then, +37% yesterday, and +600% since November's abstract lift. Funny, when I last wrote about it in May it was worth a quarter of $ELVN↗